Turnstone Estates has been granted full planning consent for Unit 1 at Pampisford Park, the south Cambridge business and science park development.
Turnstone achieves planning consent for Pampisford Park
The building, which will be the third unit on the 3.53 acre site, will comprise a 15,400 sq ft two-storey high quality business space building. Turnstone will make a speculative start in early 2006.
Chris Goldsmith, managing director of Turnstone Estates, comments: 'The take-up of Units 2 and 3 has shown the success of pampisford Park as a high-technology and biotechnology cluster and has given us the confidence to commence speculative development.'
Other tenants at Pampisford Park are Sareum Ltd, the biotech company, occupying Unit 2; and Xention Discovery, a drug discovery company, occupying Unit 3.
The letting agents are Januarys and Jeffersons Commercial.
Established in 1989, Turnstone is one of the most active and dynamic property companies in the south east of England.